Polyamines prevent DFMO-mediated inhibition of angiogenesis.
Tumor growth mainly depend on formation of new blood vessels. DFMO (alpha-difluoromethylornithine), an inhibitor of polyamine biosynthesis, inhibits tumor growth in many animal tumors. Our investigation was to evaluate the requirement of polyamines for induction of angiogenesis by tumor cells and spleen lymphocytes from tumor-bearing mice. In this regard, we have added DFMO to cell cultures. The neovascular response induced either by tumor cells or spleen lymphocytes was completely abrogated. This inhibition could be reversed by the addition of exogenous putrescine. These findings suggest that the effect of DFMO on angiogenesis is, in part, mediated by the inhibition of polyamine biosynthesis.
Jasnis
M A
MA
Instituto de Oncologia A.H. Roffo Universidad de Buenos Aires, Argentina.
Klein
S
S
Monte
M
M
Davel
L
L
Sacerdote de Lustig
E
E
Algranati
I D
ID
D000230:Adenocarcinoma / Q000098:blood supply*; D000704:Analysis of Variance; D000818:Animals; D000518:Eflornithine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005260:Female; D008214:Lymphocytes / Q000187:drug effects* / Q000502:physiology; D008325:Mammary Neoplasms, Experimental / Q000098:blood supply*; D051379:Mice; D008807:Mice, Inbred BALB C; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D011073:Polyamines / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011700:Putrescine / Q000494:pharmacology*; D013154:Spleen / Q000276:immunology
D011073:Polyamines; D011700:Putrescine; D000518:Eflornithine